Prostate artery embolization (PAE) for benign prostatic hyperplasia (BPH): efficacy and safety at 1 year
Refereed conference paper presented and published in conference proceedings


全文

其它資訊
摘要Objective: To evaluate the safety and efficacy of PAE for BPH at 1 year.
Patients and Methods: This is a prospective cohort study approved by the institutional review board. Men with prostates≥40 g, IPSS≥13, and Qmax<15 mL/s (or recurrent AROU) were recruited. Bilateral PAE was performed with 100-micron microspheres under local anaesthesia(LA).
Results: 90 men with mean age of 67 ( 6.3) were recruited. PAE was successful on both sides in 91.1%. 88.0% 22/25) on Foley could void (59% in 7 days, 81.8% in 14 days, 90.9% in 18 days).
Complications: Obstructive uropathy
(1.1%), transient lower limb claudication (1.1%), retention of necrotic prostate tissue (1.1%), passage of prostate tissue (3.3%), groin hematoma (2.2%), dysuria (10.0%), mild hematuria (2.2%), mild PR bleeding (3.3%), UTI (1.1%). There was no worsening of erectile or ejaculatory function in all men. 4.4% required TURP.
Conclusion: LA PAE was safe and effective at 1 year.
出版社接受日期08.01.2019
著者Chiu PK, Kwok KY, Yee CH, Teoh JY, Sy LI, Kwok SW, Cho CCM, Hung EHY, Ng CF, Yu SCH
會議名稱23rd Annual Scientific Meeting of the Hong Kong Urological Association, Hong Kong
會議開始日04.11.2018
會議完結日04.11.2018
會議地點Hong Kong
會議國家/地區香港
會議論文集題名BJU International
出版年份2019
月份3
卷號123
期次Suppl 1
出版社Wiley
頁次5 - 5
語言英式英語
關鍵詞prostate artery embolization (PAE), benign prostate hyperplasia (BPH)

上次更新時間 2019-22-10 於 12:49